Wird geladen...

Hepatitis B reactivation in chronic myeloid leukemia patients receiving tyrosine kinase inhibitor

Hepatitis B virus (HBV) reactivation is a well-recognized complication in patients with chronic HBV infection receiving cytotoxic or immunosuppressive chemotherapy. Imatinib mesylate and nilotinib are selective Bcr/Abl tyrosine kinase inhibitors, which are now widely used in the treatment of patient...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Lai, Guan-Min, Yan, Sheng-Lei, Chang, Cheng-Shyong, Tsai, Chien-Yu
Format: Artigo
Sprache:Inglês
Veröffentlicht: Baishideng Publishing Group Co., Limited 2013
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3587491/
https://ncbi.nlm.nih.gov/pubmed/23483799
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v19.i8.1318
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!